| Endpoints | Low-Level DSA, MFI<5000 (n=34) | No DSA Pre-HTx (n=197) | P-Value |
|---|---|---|---|
| 5 Year Survival | 93.5% | 81.2% | 0.072 |
| 5 Year Freedom from CAV | 87.1% | 84.8% | 0.451 |
| 5 Year Freedom from NF-MACE | 87.1% | 78.2% | 0.132 |
| 1 Year Freedom from Any-Treated Rejection | 77.4% | 85.8% | 0.236 |
| 1 Year Freedom from Acute Cellular Rejection | 90.3% | 91.4% | 0.898 |
| 1 Year Freedom from Antibody-Mediated Rejection | 83.9% | 97.0% | 0.002 |